Is Pan India Corpor overvalued or undervalued?
As of August 22, 2025, Pan India Corpor is considered very expensive with a PE ratio of -12.09 and has underperformed the Sensex by 33.33% year-to-date, indicating significant overvaluation compared to healthier peers like Life Insurance and Bajaj Finance.
As of 22 August 2025, the valuation grade for Pan India Corpor has moved from risky to very expensive. This indicates a significant shift in perception regarding the company's financial health and valuation. The company is currently deemed overvalued, with a PE ratio of -12.09, an EV to EBIT of -11.86, and a Price to Book Value of 5.41. These ratios highlight the company's struggles, particularly with negative earnings and returns on capital.In comparison to its peers, Pan India Corpor stands out unfavorably. For instance, Life Insurance has a PE ratio of 11.55 and an EV to EBITDA of 8.99, indicating a much healthier valuation. Similarly, Bajaj Finance, while categorized as very expensive, shows a PE ratio of 31.91 and an EV to EBITDA of 18.05, further emphasizing Pan India Corpor's overvaluation. Notably, the company's stock has underperformed relative to the Sensex over various periods, particularly year-to-date, where it has declined by 33.33% compared to the Sensex's gain of 4.05%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
